All Relations between Meningioma and matrix compartment

Reference Sentence Publish Date Extraction Date Species
Elizaveta I Safronova, Suzanna A Galstyan, Yury V Kushe. Trans-eyebrow supraorbital endoscope-assisted keyhole approach to suprasellar meningioma in pediatric patient: case report and literature review. Chinese neurosurgical journal vol 8 issue 1 2022 36104809 even in children, suprasellar meningiomas without dural matrix are rare findings mimicking more common suprasellar lesions. 2022-09-18 2022-09-20 Not clear
Chaoying Qin, Meng Huang, Yimin Pan, Yuzhe Li, Wenyong Long, Qing Li. Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options. Brain tumor pathology vol 38 issue 3 2021 33903981 here, we will highlight the mechanisms which govern brain invasion and new promising therapeutic approaches for brain-invasive meningiomas, including pharmacological approaches targeting three major aspects of tumor cell invasion: extracellular matrix degradation, cell adhesion, and growth factors, as well as other innovative treatments such as immunotherapy, hormone therapy, tumor treating fields, and biodegradable copolymers (wafers), impregnated chemotherapy. 2021-11-29 2022-01-13 Not clear
Shuvolina Mukherjee, Deeptarup Biswas, Sridhar Epari, Prakash Shetty, Aliasgar Moiyadi, Graham Roy Ball, Sanjeeva Srivastav. Comprehensive proteomic analysis reveals distinct functional modules associated with skull base and supratentorial meningiomas and perturbations in collagen pathway components. Journal of proteomics vol 246 issue 2021 34174477 in silico analysis enabled mapping of the major alterations and hinted towards an overall perturbation of extracellular matrix and collagen biosynthesis components in the non-skull base meningiomas and a prominent perturbation of molecular trafficking in the skull base meningiomas. 2021-08-10 2022-01-13 Not clear
Agbolahan A Sofela, David A Hilton, Sylwia Ammoun, Daniele Baiz, Claire L Adams, Emanuela Ercolano, Michael D Jenkinson, Kathreena M Kurian, Mario Teo, Peter C Whitfield, Felix Sahm, C Oliver Haneman. Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas. International journal of molecular sciences vol 22 issue 2 2021 33429944 in this study, we identified the calcium binding extracellular matrix glycoprotein, fibulin-2, via mass-spectrometry-based proteomics, assessed its expression in grade i and ii meningiomas and explored its potential as a grade ii biomarker. 2021-03-30 2022-01-13 Not clear
Erdinc Ozek, Deniz Ozcan, Suat Erol Celik, Ahmet Celal Iplikciogl. Matrix metalloprotease-9 expresssion in meningioma: Correlation with growth fraction and role of gender. A pilot immunohistochemical study. Clinical neurology and neurosurgery vol 172 issue 2019 30021149 matrix metalloproteases (mmps), particularly mmp2 and mmp9 increase tumor invasion and edema in meningiomas. 2019-12-26 2022-01-13 Not clear
Tetsumori Yamashim. On Arachnoid Villi and Meningiomas: Functional Implication of Ultrastructure, Cell Adhesion Mechanisms, and Extracellular Matrix Composition. Pathology oncology research : POR vol 2 issue 3 2019 11173597 on arachnoid villi and meningiomas: functional implication of ultrastructure, cell adhesion mechanisms, and extracellular matrix composition. 2019-11-20 2022-01-11 Not clear
Tetsumori Yamashim. On Arachnoid Villi and Meningiomas: Functional Implication of Ultrastructure, Cell Adhesion Mechanisms, and Extracellular Matrix Composition. Pathology oncology research : POR vol 2 issue 3 2019 11173597 arachnoid villi and meningiomas show a number of similarities in ultrastructure, cell adhesion mechanisms, and extracellular matrix composition. 2019-11-20 2022-01-11 Not clear
Li Jia, Chen Liu, Ying Xin, Aimin Zhang, Yunli Zhou, Dong Dong, Li Re. Evaluating EFEMP1 in Cerebrospinal Fluid and Serum as a Potential Diagnosis Biomarker for Meningiomas. Clinical laboratory vol 63 issue 10 2019 29035461 the aim of this study was to determine the cerebrospinal fluid (csf) and serum levels of egf containing fibulin-like extracellular matrix protein 1 (efemp1) in the patients with meningiomas and explore its potential as a biomarker. 2019-07-15 2022-01-13 Not clear
M T Mandara, A Reginato, G Foiani, S De Luca, G Guelf. Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs. Journal of veterinary internal medicine vol 31 issue 6 2018 28875568 gene expression of matrix metalloproteinases and their inhibitors (timps) in meningiomas of dogs. 2018-09-17 2022-01-13 Not clear
Numan Karaarslan, Mehmet Sabri Gurbuz, Tezcan Caliskan, Erdogan Ayan, Fugen Vardar Aker, Mehmet Zafer Berkma. The Effect of Matrix Metalloproteinase-3 on the Prognosis and Biological Behaviour of Meningiomas. Turkish neurosurgery vol 26 issue 5 2017 27438616 the effect of matrix metalloproteinase-3 on the prognosis and biological behaviour of meningiomas. 2017-04-03 2022-01-12 Not clear
Numan Karaarslan, Mehmet Sabri Gurbuz, Tezcan Caliskan, Erdogan Ayan, Fugen Vardar Aker, Mehmet Zafer Berkma. The Effect of Matrix Metalloproteinase-3 on the Prognosis and Biological Behaviour of Meningiomas. Turkish neurosurgery vol 26 issue 5 2017 27438616 to analyse the effect of mmp-3 (matrix metalloproteinase enzyme-3)-one of the extracellular matrix proteins- on the prognosis and biological behaviour of meningiomas. 2017-04-03 2022-01-12 Not clear
Shahrzad Jalali, Sanjay Singh, Sameer Agnihotri, Takafumi Wataya, Fatemeh Salehi, R Alkins, Kelly Burrell, Roya Navab, Sidney Croul, Kenneth Aldape, Gelareh Zade. A role for matrix remodelling proteins in invasive and malignant meningiomas. Neuropathology and applied neurobiology vol 41 issue 2 2015 24989599 a role for matrix remodelling proteins in invasive and malignant meningiomas. 2015-12-30 2022-01-12 Not clear
Mustafa Efendioglu, Recep Basaran, Omer Faruk Bayrak, Nejat Isik, Tuncay Kaner, Fikrettin Sahin, Bulent Guclu, Ilhan Elmac. The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region in invasion and prognosis of meningiomas. Turkish neurosurgery vol 24 issue 5 2015 25269045 the role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region in invasion and prognosis of meningiomas. 2015-09-11 2022-01-12 Not clear
Kuniaki Tanahashi, Atsushi Natsume, Fumiharu Ohka, Kazuya Motomura, Adiljan Alim, Ichidai Tanaka, Takeshi Senga, Ichiro Harada, Ryuichi Fukuyama, Naoyuki Sumiyoshi, Yoshitaka Sekido, Toshihiko Wakabayash. Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness. Journal of neuropathology and experimental neurology vol 74 issue 7 2015 26049897 activation of yes-associated protein in low-grade meningiomas is regulated by merlin, cell density, and extracellular matrix stiffness. 2015-08-24 2022-01-12 Not clear
Thomas Backer-Gr\\xc3\\xb8ndahl, Bj\\xc3\\xb8rnar H Moen, Magnus B Arnli, Kathrin Torseth, Sverre H Tor. Immunohistochemical characterization of brain-invasive meningiomas. International journal of clinical and experimental pathology vol 7 issue 10 2015 25400818 sections stained using antibodies against ki-67/mib-1, phospohistone-h3 (phh3), matrix metalloproteinase-9 (mmp-9), cathepsin d, plasminogen activator inhibitor-1 (pai-1), and e-cadherin antigens were used to characterize brain-invasive meningiomas and to investigate the process of brain invasion. 2015-07-06 2022-01-12 Not clear
\\xc4\\xb0lker Coven, Ozge Ozer, Ozlem Ozen, Feride \\xc4\\xb0ffet \\xc5\\x9eahin, Nur Altinor. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. Journal of neurosurgery vol 121 issue 6 2015 25259564 presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. 2015-01-27 2022-01-12 Not clear
\\xc4\\xb0lker Coven, Ozge Ozer, Ozlem Ozen, Feride \\xc4\\xb0ffet \\xc5\\x9eahin, Nur Altinor. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. Journal of neurosurgery vol 121 issue 6 2015 25259564 to investigate the behavioral characteristics of meningiomas, researchers have studied matrix metalloproteinases (mmps), their tissue inhibitors (timps), interstitial collagens, proteins, vascular endothelial growth factors (vegf), and tumor necrosis factors. 2015-01-27 2022-01-12 Not clear
Jie Gong, Shu-gan Zhu, Cheng-yuan Wu, Xin-gang Li, Yu-guang Liu, Xiao-hui Ren, Yuan Zhan. [Expression and significance of MMP-9, PR, Ki-67 and Survivin in multiple meningiomas]. Zhonghua yi xue za zhi vol 92 issue 45 2013 23328471 to detect the expressions of matrix metalloproteinase-9(mmp-9), progesterone receptor(pr), ki-67 and survivin in the multiple meningiomas (mms) and explore its genesis, diagnosis and bionomics features. 2013-11-25 2022-01-12 Not clear
Bo Li, Feng Li, Lingyi Chi, Liangwen Zhang, Shugan Zh. The expression of SPARC in human intracranial aneurysms and its relationship with MMP-2/-9. PloS one vol 8 issue 3 2013 23516489 sparc can change the composition and structure of the matrix and promote angiogenesis; these effects are closely related to clinical stage and the prognosis of tumors such as meningiomas. 2013-09-17 2022-01-12 Not clear
Quan Huang, Song-Li Zhao, Xiao-Ying Tian, Bin Li, Zhi L. Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma. International journal of medical sciences vol 10 issue 3 2013 23372434 we detected the expression of mif and matrix metalloproteinase 9 (mmp9) in meningiomas to determine whether they are valuable recurrence predictor for meningioma. 2013-07-12 2022-01-12 Not clear
Page: 
1   2   3   4